Jason A. Roberts
Researcher Next ID · RN-032724
Researcher · Biochemistry, Genetics and Molecular Biology
Brisbane, France
- Works count
- 1,033
- Citation count
- 54,100
- H-index
- 102
- i10-index
- 558
Research interests
Publications
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Intensive Care Medicine · 2021 · https://doi.org/10.1007/s00134-021-06506-y
Executive Summary: Surviving Sepsis Campaign: International Guidelines for the Management of Sepsis and Septic Shock 2021
Critical Care Medicine · 2021 · https://doi.org/10.1097/ccm.0000000000005357
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021
Critical Care Medicine · 2021 · https://doi.org/10.1097/ccm.0000000000005337
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
Intensive Care Medicine · 2020 · https://doi.org/10.1007/s00134-020-06050-1
The Effect of Renal Replacement Therapy and Antibiotic Dose on Antibiotic Concentrations in Critically Ill Patients: Data From the Multinational Sampling Antibiotics in Renal Replacement Therapy Study
Clinical Infectious Diseases · 2020 · https://doi.org/10.1093/cid/ciaa224
Obesity in the critically ill: a narrative review
Intensive Care Medicine · 2019 · https://doi.org/10.1007/s00134-019-05594-1
Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA)
World Journal of Emergency Surgery · 2016 · https://doi.org/10.1186/s13017-016-0089-y
Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis: A Meta-analysis of Individual Patient Data from Randomized Trials
American Journal of Respiratory and Critical Care Medicine · 2016 · https://doi.org/10.1164/rccm.201601-0024oc
Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis
Intensive Care Medicine · 2016 · https://doi.org/10.1007/s00134-015-4188-0
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
Clinical Infectious Diseases · 2016 · https://doi.org/10.1093/cid/ciw353
Executive Summary: Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
Clinical Infectious Diseases · 2016 · https://doi.org/10.1093/cid/ciw504
Protein-bound drugs are prone to sequestration in the extracorporeal membrane oxygenation circuit: results from an ex vivo study
Critical Care · 2015 · https://doi.org/10.1186/s13054-015-0891-z
An international, multicentre survey of -lactam antibiotic therapeutic drug monitoring practice in intensive care units
Journal of Antimicrobial Chemotherapy · 2014 · https://doi.org/10.1093/jac/dkt523
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
Clinical Infectious Diseases · 2014 · https://doi.org/10.1093/cid/ciu027
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
The Lancet Infectious Diseases · 2014 · https://doi.org/10.1016/s1473-3099(14)70036-2
Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind, Randomized Controlled Trial
Clinical Infectious Diseases · 2012 · https://doi.org/10.1093/cid/cis856
Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation
Journal of Critical Care · 2012 · https://doi.org/10.1016/j.jcrc.2012.02.013
The Clinical Relevance of Plasma Protein Binding Changes
Clinical Pharmacokinetics · 2012 · https://doi.org/10.1007/s40262-012-0018-5
Subtherapeutic Initial β-Lactam Concentrations in Select Critically Ill Patients
CHEST Journal · 2011 · https://doi.org/10.1378/chest.11-1671
Therapeutic drug monitoring of antimicrobials
British Journal of Clinical Pharmacology · 2011 · https://doi.org/10.1111/j.1365-2125.2011.04080.x
Therapeutic drug monitoring of β-lactams in critically ill patients: proof of concept
International Journal of Antimicrobial Agents · 2010 · https://doi.org/10.1016/j.ijantimicag.2010.06.008
The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients
Clinical Pharmacokinetics · 2010 · https://doi.org/10.2165/11539220-000000000-00000
Augmented Renal Clearance
Clinical Pharmacokinetics · 2009 · https://doi.org/10.2165/11318140-000000000-00000
Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution
Journal of Antimicrobial Chemotherapy · 2009 · https://doi.org/10.1093/jac/dkp139
Pharmacokinetic issues for antibiotics in the critically ill patient
Critical Care Medicine · 2009 · https://doi.org/10.1097/ccm.0b013e3181961bff
Antibiotic resistance—What’s dosing got to do with it?
Critical Care Medicine · 2008 · https://doi.org/10.1097/ccm.0b013e318180fe62
Antibacterial Dosing in Intensive Care
Clinical Pharmacokinetics · 2006 · https://doi.org/10.2165/00003088-200645080-00001
Current projects
No projects listed.